After solid-phase synthesis, cleavage, preparative HPLC purification and lyophilisation, a research peptide is rarely completely free of the chemicals that made the synthesis and purification process possible. Besides the water content, which is usually determined by Karl Fischer titration, traces remain of the organic solvents used during synthesis and work-up. Gas chromatography (GC) is the analytical technique with which laboratories identify and quantify these residual solvents, as a complement to the usual HPLC and MS characterisation.
Where residual solvents come from
In Fmoc SPPS, DMF (dimethylformamide) and NMP (N-methylpyrrolidone) are used as the reaction medium for coupling, washing steps and Fmoc deprotection. After cleavage from the resin, the crude peptide often still contains traces of dichloromethane (DCM), which is used in resin washes and some cleavage protocols, and of trifluoroacetic acid (TFA) from the cleavage cocktail itself. In the subsequent preparative HPLC purification, acetonitrile (ACN) comes into play as the mobile phase. Each of these substances can, in variable amounts, survive the lyophilisation step if it has not been completely evaporated or exchanged.
Classification of solvents: an analytical frame of reference
Within analytical chemistry, solvents are often classified according to the ICH Q3C guideline, which distinguishes three classes on the basis of toxicological profile and the reporting thresholds derived from it. DMF and NMP generally fall into class 2, as does DCM; ACN is likewise regarded as a class 2 solvent. This framework was developed primarily for the pharmaceutical industry, but laboratories that document research material analytically often use the same classification as a reference point in order to report residual levels consistently and compare them between batches. This is an analytical-chemical classification system for documentation purposes, not a statement about use in humans or animals.
Headspace GC: how the measurement works
For volatile residual solvents in a solid, lyophilised sample, headspace GC is usually chosen. The sample is brought to a fixed temperature in a sealed vial, so that volatile components distribute into the gas phase above the sample according to their vapour pressure. A defined volume of that gas phase is then automatically injected onto the GC column, where separation takes place on the basis of volatility and polarity. Detection is carried out with a flame ionisation detector (FID) for quantification, or with a mass spectrometer (GC-MS) when identification of unknown peaks is needed. Headspace injection has the advantage that non-volatile matrix components, such as the peptide itself, do not burden the column and detector.
Calibration and limits of quantification
Quantitative headspace GC requires a calibration series with known concentrations of each target solvent, usually prepared in a matrix that approximates the equilibrium distribution of the real sample. Internal standards correct for variation in injection volume and headspace equilibration. The reporting limit (limit of quantification) for most class 2 solvents is in the order of a few tens to hundreds of ppm, well below what would be detectable with simple NMR analysis. This sensitivity is relevant because residual solvents, even in small amounts, can affect the accuracy of gravimetric determinations of the net peptide content and in some cases give interfering signals in related analytical techniques.
Why this is part of full characterisation
For research groups that want to safeguard reproducibility between experiments, documenting residual solvents is a logical part of the full analytical fingerprint of a peptide batch, alongside purity (HPLC), identity (MS) and water content (Karl Fischer). Batch-to-batch variation in residual solvents can, after all, explain small differences in behaviour between apparently identical peptide lots in follow-up research. A complete certificate of analysis that also states residual solvent values therefore gives researchers a fuller picture of the material they have in hand.
These products and information are intended solely for laboratory and research purposes and not for human or animal consumption, diagnostic use or therapeutic application.
